New mechanistic insights into the role of inflammatory molecules in cancer progression
Immune checkpoint inhibitors have revolutionized cancer treatment, yet many colorectal tumors remain resistant. Even among patients who initially respond, more than half eventually develop resistance, highlighting the need to better understand how tumors evade immune attack.
We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.